Free Trial

Raia Drogasil S.A. (OTCMKTS:RADLY) Sees Significant Decline in Short Interest

Raia Drogasil logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest plunged 78.5%, falling from 42,192 shares on March 15 to 9,083 shares on March 31, with a short-interest ratio of 0.9 days and approximately 0.0% of shares shorted.
  • Shares opened at $4.95, with a 50-day moving average of $4.75 and a 200-day moving average of $4.36, and a one-year trading range of $2.17 to $5.34.
  • Raia Drogasil is a leading Brazilian pharmacy operator, formed by the 2011 merger of Drogasil and Droga Raia and offering prescriptions, OTC products, personal care items and in-store health services.
  • MarketBeat previews top five stocks to own in May.

Raia Drogasil S.A. (OTCMKTS:RADLY - Get Free Report) was the recipient of a large drop in short interest in the month of March. As of March 31st, there was short interest totaling 9,083 shares, a drop of 78.5% from the March 15th total of 42,192 shares. Based on an average daily volume of 9,903 shares, the short-interest ratio is presently 0.9 days. Approximately 0.0% of the shares of the stock are short sold.

Raia Drogasil Price Performance

Shares of OTCMKTS:RADLY opened at $4.95 on Friday. The firm has a fifty day moving average price of $4.75 and a two-hundred day moving average price of $4.36. Raia Drogasil has a one year low of $2.17 and a one year high of $5.34.

Raia Drogasil Company Profile

(Get Free Report)

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Raia Drogasil Right Now?

Before you consider Raia Drogasil, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Raia Drogasil wasn't on the list.

While Raia Drogasil currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines